Flomics Biotech

Flomics is a biotechnology company that combines next-generation sequencing (NGS) of cell-free RNA with machine learning to develop a liquid biopsy blood test for early cancer detection and screening. It also offers tailored genomics services, including NGS data analysis, biomarker discovery, metagenomics, and SARS-CoV-2 variant identification, and operates the Stratus data analysis cloud platform.

Customers named on the website are research and clinical institutions, including hospitals, research centres and a company in the life sciences sector, that run genomics R&D or clinical studies. Genomics services are scoped per project, and the site does not describe pricing or the commercial model for the blood test.

Flomics is registered in Spain. The website lists CEO and co-founder João Curado, PhD, and a team including a Genomics Lead and bioinformatics scientists, with advisors from academic and clinical institutions. Two open positions are listed, a Bioinformatics Senior Scientist and a Business Development Associate, both under Cosymbio Labs - Flomics Biotech. The founding year and office locations are not stated.

Product: Liquid biopsy blood test based on NGS of cell-free RNA with machine learning; tailored genomics services; Stratus data analysis cloud platform.